Company news
Cytophage Technologies Ltd. news in 2025
Cytophage Technologies Ltd.'s news releases, calls and decks from 2025, newest first.
Cytophage Announces Closing of Non-Brokered Private Placement and Filing of Q3 Financials
November 28, 2025
Cytophage Announces Closing of First Tranche of Non-Brokered Private Placement
November 12, 2025
Cytophage Announces Closing Date of its Non-Brokered Private Placement
November 5, 2025
Cytophage Announces Non-Brokered Private Placement
October 17, 2025
Cytophage Announces the Commercialization of OvaPhage in Canada Through W.L.T. Distributors Inc.
October 16, 2025
Cytophage Receives Federal Support for Entry into European Market through France Biomanufacturing Mission
September 29, 2025
Cytophage Reports Successful Results and Data from Second EU Pilot Study for AviPhage
September 23, 2025
Cytophage Identifies Two New Patient Candidates for Phage Therapy for Prosthetic Joint Infections
September 11, 2025
Cytophage Secures Health Canada Validation for OvaPhage and PhageFend Products for use in Food Safety
August 25, 2025
Cytophage Welcomes New Chairman Thomas Wellner and Announces Grant of Options and RSUs
August 1, 2025
Cytophage Technologies Reports Successful E. Coli Containment in EU Pilot Study for AviPhage
July 28, 2025
Cytophage Announces Closing of Upsized Non-Brokered Private Placement
June 10, 2025
Cytophage Announces Mailing of Annual and Special Meeting Materials with Board Nominees
June 3, 2025
Cytophage Announces Upsizing of its Non-Brokered Private Placement
May 29, 2025
Cytophage Technologies Ltd. Secures Government of Canada New Substance Notification Approval to Facilitate Enterococcus Phage Therapy Trials
May 8, 2025
Cytophage Enters European Poultry Market with Start of AviPhage Pilot Study
April 30, 2025
Cytophage Announces Development of New Phage-Based H5N1 Vaccine and Advancement Toward Preclinical Trials
February 27, 2025
Cytophage Named Bioscience Company of the Year by Bioscience Association Manitoba
February 20, 2025
Cytophage Launches Incubator Egg Trials for OvaPhage in Partnership with Leading Canadian Hatchery
February 5, 2025
Decks in 2025
- Investor Presentation (October 2025)
Investor deck · 35 slides · October 2025
- Investor Presentation (February 2025)
Investor deck · 32 slides · February 2025